The dual legacy of BCG: a century of tuberculosis prevention and the evolving pursuit of trained immunity-based therapies.

Ahmed N, Jawaid F, Nabeel M.

Open source

DOI
10.1080/1750743x.2026.2698221
Published
2026-06-01
Container
Immunotherapy
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/1750743x.2026.2698221,
  title = {The dual legacy of BCG: a century of tuberculosis prevention and the evolving pursuit of trained immunity-based therapies.},
  author = {Ahmed N and  Jawaid F and  Nabeel M.},
  year = {2026},
  journal = {Immunotherapy},
  doi = {10.1080/1750743x.2026.2698221},
  url = {https://doi.org/10.1080/1750743x.2026.2698221}
}

RIS

TY  - JOUR
TI  - The dual legacy of BCG: a century of tuberculosis prevention and the evolving pursuit of trained immunity-based therapies.
AU  - Ahmed N
AU  -  Jawaid F
AU  -  Nabeel M.
PY  - 2026
JO  - Immunotherapy
DO  - 10.1080/1750743x.2026.2698221
UR  - https://doi.org/10.1080/1750743x.2026.2698221
ER  - 

APA

N, A., F, J., & M., N. (2026). The dual legacy of BCG: a century of tuberculosis prevention and the evolving pursuit of trained immunity-based therapies.. Immunotherapy. https://doi.org/10.1080/1750743x.2026.2698221

Source records